OncoSenX
Late stage pre-clinical cancer company targeting solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.
The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.
Visit website: https://www.oncosenx.com/
See also: Oisin Biotechnologies - Drug development company focused on the senolytic technology to fight age-related diseases
Details last updated 06-Nov-2019
OncoSenX News
OncoSenX raises more funds for cancer therapy, plans for clinical trial
GeekWire - 11-May-2020
Allowing developments on tech that will kill cancer based on their genetics
Read more...Fight Aging! reports back from SENS Research Foundation Pitch Day
Fight Aging! - 20-Jan-2020
When some of these succeed in human trials even more money will pile in to fund further advances
Read more...OncoSenX targets solid tumours with senolytics
Lifespan.io (LEAF) - 22-Oct-2019
Phase 1 clinical trial starting early 2020
Read more...